| Literature DB >> 30370310 |
Yuri Feito1, Evanette K Burrows2, Loni Philip Tabb2.
Abstract
BACKGROUND: High-intensity functional training (HIFT) is a new training modality that merges high-intensity exercise with functional (multijoint) movements. Even though others exist, CrossFit training has emerged as the most common form of HIFT. Recently, several reports have linked CrossFit training to severe injuries and/or life-threatening conditions, such as rhabdomyolysis. Empirical evidence regarding the safety of this training modality is currently limited.Entities:
Keywords: HIFT; exercise; high-intensity functional training; injury; safety; sports; training
Year: 2018 PMID: 30370310 PMCID: PMC6201188 DOI: 10.1177/2325967118803100
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Distribution of Age by Sex
| Age, y | Female | Male | Total |
|---|---|---|---|
| <25 | 112 (3.7) | 151 (5.0) | 263 (8.6) |
| 25-29 | 268 (8.8) | 260 (8.5) | 528 (17.3) |
| 30-34 | 312 (10.2) | 318 (10.4) | 630 (20.7) |
| 35-39 | 272 (8.9) | 266 (8.7) | 538 (17.6) |
| 40-44 | 184 (6.0) | 208 (6.8) | 392 (12.9) |
| 45-49 | 164 (5.4) | 166 (5.4) | 330 (10.8) |
| 50-54 | 98 (3.2) | 111 (3.6) | 209 (6.9) |
| ≥55 | 73 (2.4) | 86 (2.8) | 159 (5.2) |
| Total | 1483 (48.6) | 1566 (51.3) | 3049 (100.0) |
Data are shown as n (%).
Figure 1.Flowchart of the total number of respondents and surveys completed.
Distribution of Injuries, Training, and Participation in CrossFit by Sex
| Female | Male | Total |
| |
|---|---|---|---|---|
| Experienced an injury | .1989 | |||
| Yes | 436 (14.3) | 495 (16.2) | 931 (30.5) | |
| No | 1047 (34.3) | 1071 (35.1) | 2118 (69.5) | |
| No. of injuries (n = 931) | .0037 | |||
| Single | 294 (31.6) | 287 (30.8) | 581 (62.4) | |
| Multiple | 142 (15.3) | 208 (22.3) | 350 (37.6) | |
| Experience in CrossFit training, y | .0461 | |||
| <1 | 348 (11.4) | 324 (10.6) | 672 (22.0) | |
| 1-3 | 553 (18.1) | 563 (18.5) | 1116 (36.6) | |
| >3 | 582 (19.1) | 679 (22.3) | 1261 (41.4) | |
| Weekly participation, d/wk | <.001 | |||
| <3 | 162 (5.3) | 112 (3.6) | 274 (9.0) | |
| 3-5 | 804 (26.4) | 799 (26.2) | 1603 (52.6) | |
| >5 | 517 (17.0) | 655 (21.5) | 1172 (38.4) | |
Data are shown as n (%).
Figure 2.Distribution of the location of injuries between male and female participants.
Number of Injuries and Incidence Rates per 1000 Hours
| No. of Injuries | Incidence Rate per 1000 Hours | ||
|---|---|---|---|
| Minimum | Maximum | ||
| Overall | 931 | 0.74 | 0.27 |
| Sex | |||
| Female | 436 | 0.78 | 0.28 |
| Male | 495 | 0.70 | 0.26 |
| Age group, y | |||
| <25 | 67 | 0.80 | 0.27 |
| 25-29 | 147 | 0.68 | 0.25 |
| 30-34 | 183 | 0.73 | 0.26 |
| 35-39 | 170 | 0.71 | 0.27 |
| 40-44 | 123 | 0.73 | 0.27 |
| 45-49 | 114 | 0.82 | 0.30 |
| 50-54 | 72 | 0.84 | 0.30 |
| ≥55 | 55 | 0.73 | 0.28 |
| Weekly participation, d/wk | |||
| <3 | 76 | 2.46 | 0.54 |
| 3-5 | 488 | 0.90 | 0.30 |
| >5 | 367 | 0.53 | 0.22 |
| No. of weekly workouts | |||
| 1-3 | 158 | 3.61 | 0.61 |
| 4-6 | 607 | 0.81 | 0.29 |
| 7-9 | 126 | 0.39 | 0.17 |
| ≥10 | 40 | 0.26 | 0.11 |
| Experience in CrossFit training | |||
| <6 mo | 36 | 3.90 | 1.15 |
| 6-12 mo | 132 | 3.21 | 1.01 |
| 1-3 y | 361 | 1.57 | 0.34 |
| 3-5 y | 312 | 0.50 | 0.20 |
| >5 y | 90 | 0.25 | 0.14 |
Minimum has the assumptions of the lowest weekly participation, lowest frequency of weekly workouts, and 50 weeks per year of CrossFit training. Maximum has the assumptions of the highest weekly participation, highest frequency of weekly workouts, and 52 weeks per year of CrossFit training.
Incidence Rates per 1000 Hours by Sex, Weekly Participation, and Age Group
| n | Incidence Rate per 1000 Hours | ||
|---|---|---|---|
| Minimum | Maximum | ||
| Female | |||
| <3 d/wk | |||
| <25 y | 9 | 3.48 | 0.47 |
| 25-29 y | 23 | 1.54 | 0.35 |
| 30-34 y | 33 | 2.87 | 0.48 |
| 35-39 y | 24 | 3.08 | 0.69 |
| 40-44 y | 24 | 1.67 | 0.33 |
| 45-49 y | 26 | 3.46 | 0.63 |
| 50-54 y | 13 | 2.38 | 0.63 |
| ≥55 y | 10 | 1.85 | 0.48 |
| 3-5 d/wk | |||
| <25 y | 43 | 1.48 | 0.41 |
| 25-29 y | 119 | 0.96 | 0.32 |
| 30-34 y | 169 | 0.87 | 0.27 |
| 35-39 y | 161 | 0.84 | 0.29 |
| 40-44 y | 107 | 0.81 | 0.26 |
| 45-49 y | 98 | 0.93 | 0.31 |
| 50-54 y | 59 | 0.95 | 0.34 |
| ≥55 y | 48 | 0.77 | 0.27 |
| >5 d/wk | |||
| <25 y | 60 | 0.81 | 0.28 |
| 25-29 y | 126 | 0.63 | 0.22 |
| 30-34 y | 110 | 0.64 | 0.25 |
| 35-39 y | 87 | 0.51 | 0.21 |
| 40-44 y | 53 | 0.79 | 0.30 |
| 45-49 y | 40 | 0.46 | 0.20 |
| 50-54 y | 26 | 0.29 | 0.11 |
| ≥55 y | 15 | 0.37 | 0.18 |
| Male | |||
| <3 d/wk | |||
| <25 y | 5 | — | — |
| 25-29 y | 15 | 2.20 | 0.47 |
| 30-34 y | 21 | 2.25 | 0.60 |
| 35-39 y | 18 | 2.10 | 0.60 |
| 40-44 y | 17 | 4.49 | 0.75 |
| 45-49 y | 13 | 1.08 | 0.25 |
| 50-54 y | 11 | 2.46 | 0.53 |
| ≥55 y | 12 | 3.90 | 0.97 |
| 3-5 d/wk | |||
| <25 y | 53 | 1.27 | 0.37 |
| 25-29 y | 103 | 0.79 | 0.27 |
| 30-34 y | 149 | 0.90 | 0.30 |
| 35-39 y | 148 | 0.93 | 0.32 |
| 40-44 y | 118 | 0.81 | 0.29 |
| 45-49 y | 106 | 0.93 | 0.33 |
| 50-54 y | 72 | 1.13 | 0.37 |
| ≥55 y | 50 | 0.79 | 0.28 |
| >5 d/wk | |||
| <25 y | 93 | 0.56 | 0.20 |
| 25-29 y | 142 | 0.50 | 0.20 |
| 30-34 y | 148 | 0.51 | 0.20 |
| 35-39 y | 100 | 0.40 | 0.17 |
| 40-44 y | 73 | 0.44 | 0.19 |
| 45-49 y | 47 | 0.64 | 0.28 |
| 50-54 y | 28 | 0.44 | 0.18 |
| ≥55 y | 24 | 0.43 | 0.19 |